The TOMA Difference

Simple, efficient & meaningful technology

The Challenges

Identifying alterations in an individual tumor is a difficult taks. While technology to sequence DNA has advanced rapidly in recent years, significant challenges still remain:

  • Scarce amount of tissue
  • Highly complex mixture of cancer and normal cells
  • Fragmented and damaged DNA from fixation and storage

TOMA Solution

Our proprietary technology overcomes these obstacles to reveal the most clinically meaningful data even from low volume and poor quality cancer samples.

Our simplified, highly efficient single-stranded library preparation method:

  • Minimizes sample loss
  • Amplifies only targets of interest instead of the whole genome
  • End-to-end library preparation in as little as 15 hours, no over night incubation required
  • Detects down to a 2% variant allele frequency
  • Completes target enrichment within two hours
Product Data Sheet

The SIGNOME Tumor Profiling SystemTM delivers comprehensive analysis of the most relevant cancer genes across all tumor types, including genes well established in literature for lung, breast, ovarianĀ and many more cancers.

Read more…

Our standard gene specific module enables the analysis of 130 of the most relevant cancer genes. However, the technology is customizable to any genes of interest or a subset of genes for a specific tumor type.

TOMA OS-Seq Technology Platform

– versatile and customizable

The TOMA OS-Seq technology platform includes a comprehensive set of reagents to enable cancer genomics. Laboratories can run a standards panel or order a custom set of genes for analysis.